MSL
SRDX

Mackay Shields LLC’s Surmodics SRDX Stock Holding History

Mackay Shields LLC’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,200
Closed -$404K – 1251
2021
Q1 		$404K Sell
7,200
-5,100
-41% -$254K ﹤0.01% 1254
2020
Q4 		$535K Buy
+12,300
New +$484K ﹤0.01% 1245
2019
Q4 		– Sell
-34,400
Closed -$1.57M – 1460
2019
Q3 		$1.57M Buy
+34,400
New +$1.5M 0.01% 995
2019
Q2 		– Sell
-30,431
Closed -$1.32M – 1499
2019
Q1 		$1.32M Buy
30,431
+4,100
+16% +$209K 0.01% 902
2018
Q4 		$1.24M Buy
26,331
+12,631
+92% +$757K 0.01% 863
2018
Q3 		$1.02M Sell
13,700
-6,100
-31% -$420K 0.01% 873
2018
Q2 		$1.09M Buy
+19,800
New +$915K 0.01% 932

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Mackay Shields LLC's SRDX Position: Q2 2021 in Review

Mackay Shields LLC sold out of Surmodics (SRDX) in Q2 2021, closing a stake of 7,200 shares — an estimated $404K sold.

Mackay Shields LLC first reported a position in SRDX in Q2 2018 and held it in 7 quarters. The position peaked at $1.57M in Q3 2019. 147 funds tracked by Wall St. Rank hold SRDX as of Q2 2021.

  • Mackay Shields LLC reported no remaining Surmodics position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 7,200 Surmodics shares in Q2 2021, an estimated $404K.
  • Mackay Shields LLC first reported a position in Surmodics in Q2 2018 and held it in 7 quarters.
  • Mackay Shields LLC's Surmodics position peaked at $1.57M in Q3 2019.
  • 147 funds tracked by Wall St. Rank held Surmodics as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.